Novo Nordisk ADR (NYSE:NVO) currently has a daily average trading volume of 9.65M but it saw 8983441 shares traded in last market. With a market cap of 229.57B USD, the company’s current market price of $68.20 remained unchanged while comparing to the previous closing price of $68.20. In past 52 weeks, the stock remained buoying in the range of price level as high as $148.15 and as low as $57.00.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BMO Capital Markets which downgraded the stock as “Market Perform” in its note to investors issued on April 17, 2025, recommending a price target of $64 for it.
Over the week, NVO’s stock price is moving 5.88% up while it is 13.84% when we observe its performance for the past one month. Year-to-date it is -20.72% down and over the past year, the stock is showing a downside performance of -48.29%.
Currently, Novo Nordisk ADR’s total number of outstanding shares is 3.37B with 0.01% of that held by the insiders while 9.88% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 44.25% and return on equity (ROE) at 87.53%. It has a price to earnings ratio (P/E ratio) of 20.23 while having a 14.48 of forward P/E ratio. Stock’s beta reads 0.65. Stock has a price to book (P/B) ratio of 15.10 while price to sale or P/S ratio amounts to 5.27. Its return on asset (ROA) is 26.37% on average.
